Amdoxovir
Amdoxovir is a pharmaceutical drug that has undergone research for the treatment of HIV/AIDS. It acts as a nucleoside reverse transcriptase inhibitor (NRTI). The drug was discovered by Raymond F. Schinazi (Emory University) and C.K. Chu (University of Georgia) and developed by . Amdoxovir was in advanced Phase II clinical trials around 2010. In 2013, a Phase II trial was terminated and another was withdrawn before it started. No further studies appear to have been done.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Amdoxovir
Amdoxovir is a pharmaceutical drug that has undergone research for the treatment of HIV/AIDS. It acts as a nucleoside reverse transcriptase inhibitor (NRTI). The drug was discovered by Raymond F. Schinazi (Emory University) and C.K. Chu (University of Georgia) and developed by . Amdoxovir was in advanced Phase II clinical trials around 2010. In 2013, a Phase II trial was terminated and another was withdrawn before it started. No further studies appear to have been done.
has abstract
Amdoxovir is a pharmaceutical ...... dies appear to have been done.
@en
CAS number
145514-04-1
ChEMBL
FDA UNII code
54I81H0M9C
KEGG
PubChem
Wikipage page ID
15.564.595
page length (characters) of wiki page
Wikipage revision ID
1.021.890.044
Link from a Wikipage to another Wikipage
ATC prefix
none
@en
CAS number
ChEMBL
ChemSpiderID
IUPAC name
[-4--1,3-dioxolan-2-yl]methanol
@en
KEGG
D02890
@en
NIAID ChemDB
PubChem
SMILES
n2c1cN
@en
StdInChIKey
RLAHNGKRJJEIJL-RFZPGFLSSA-N
@en
verifiedrevid
437.146.369
Watchedfields
changed
@en
wikiPageUsesTemplate
subject
hypernym
comment
Amdoxovir is a pharmaceutical ...... dies appear to have been done.
@en
label
Amdoxovir
@de
Amdoxovir
@en